Accessibility information | Access Keys

The pharmacokinetics of the DC Bead were determined in preclinical and clinical studies. PRECISION II data are shown on the graph and compared to conventional TACE, PRECISION TACE reduces the peak systemic blood plasma levels by more than 99%. PRECISION I 6-month data confirmed these results and were presented at AASLD 2005.
The products may not be available for sale, may not be registered, approved or cleared for use as claimed, in all countries where Biocompatibles is represented.
© 2010 Biocompatibles UK Ltd - All rights reserved - Site map - Terms & conditions - Accessiblity - Help - Glossary